Norgine Drug Patent Portfolio
Norgine owns 1 orange book drug protected by 11 US patents Given below is the list of Norgine's drug patents along with their expiration dates.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10016504 | Compositions | 10 Sep, 2033 | Active |
| US10918723 | Colon cleansing compositions and methods of use | 10 Sep, 2033 | Active |
| US12083179 | Colon cleansing compositions and method of use | 10 Sep, 2033 | Active |
| US8999313 | Compositions | 10 Sep, 2033 | Active |
| US9326969 | Compositions | 10 Sep, 2033 | Active |
| US9707297 | Compositions | 10 Sep, 2033 | Active |
| US9592252 | Colonoscopy—preparation | 11 Aug, 2032 | Active |
| US10646512 | Colonoscopy - preparation | 25 Mar, 2032 | Active |
| US10780112 | Colonoscopy-preparation | 09 Mar, 2032 | Active |
| US10792306 | Colonoscopy—preparation | 09 Mar, 2032 | Active |
| US11529368 | Colonoscopy—preparation | 09 Mar, 2032 | Active |
Latest Legal Activities on Norgine's Drug Patents
Given below is the list of recent legal activities going on the following drug patents of Norgine.
| Activity | Date | Patent Number |
|---|---|---|
 | ||
| Payment of Maintenance Fee, 8th Year, Large Entity | 15 Dec, 2025 | US10016504 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 23 Dec, 2024 | US9707297 |
| Email Notification | 10 Sep, 2024 | US12083179 |
| Mail Patent eGrant Notification | 10 Sep, 2024 | US12083179 |
| Recordation of Patent Grant Mailed | 10 Sep, 2024 | US12083179 |
| Patent Issue Date Used in PTA Calculation | 10 Sep, 2024 | US12083179 |
| Patent eGrant Notification | 10 Sep, 2024 | US12083179 |
| Recordation of Patent eGrant | 10 Sep, 2024 | US12083179 |
| Email Notification | 22 Aug, 2024 | US12083179 |
| Payment of Maintenance Fee, 8th Year, Large Entity | 21 Aug, 2024 | US9592252 |
| Issue Notification Mailed | 21 Aug, 2024 | US12083179 |
| Application Is Considered Ready for Issue | 08 Aug, 2024 | US12083179 |
| Dispatch to FDC | 08 Aug, 2024 | US12083179 |
| Issue Fee Payment Verified | 07 Aug, 2024 | US12083179 |
| Issue Fee Payment Received | 07 Aug, 2024 | US12083179 |
Norgine's Family Patents
Norgine drugs have patent protection in a total of 36 countries. It's US patent count contributes only to 11.3% of its total global patent coverage. 1 country has all of their patents expired or invalidated which has opened up potential generic launch opportunities in this particular country. Click
below to unlock the full patent family tree.
Norgine Drug List
Given below is the complete list of Norgine's drugs and the patents protecting them.
1. Plenvu
Plenvu is protected by 11 patents, out of which none have expired yet. Check out its patent list below.
| Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Status |
|---|---|---|---|
| US10016504 | Compositions |
10 Sep, 2033
(6 years from now)
| Active |
| US10918723 | Colon cleansing compositions and methods of use |
10 Sep, 2033
(6 years from now)
| Active |
| US12083179 | Colon cleansing compositions and method of use |
10 Sep, 2033
(6 years from now)
| Active |
| US8999313 | Compositions |
10 Sep, 2033
(6 years from now)
| Active |
| US9326969 | Compositions |
10 Sep, 2033
(6 years from now)
| Active |
| US9707297 | Compositions |
10 Sep, 2033
(6 years from now)
| Active |
| US9592252 | Colonoscopy—preparation |
11 Aug, 2032
(5 years from now)
| Active |
| US10646512 | Colonoscopy - preparation |
25 Mar, 2032
(5 years from now)
| Active |
| US10780112 | Colonoscopy-preparation |
09 Mar, 2032
(5 years from now)
| Active |
| US10792306 | Colonoscopy—preparation |
09 Mar, 2032
(5 years from now)
| Active |
| US11529368 | Colonoscopy—preparation |
09 Mar, 2032
(5 years from now)
| Active |
Discover which of these patents contain the active ingredient(API) of the drug, their family patents, along with litigation and legal activity details of these patents on Plenvu's drug page
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List